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Pacheco-Pinedo EC, Budak MT, Zeiger U, Jørgensen LH, Bog-
danovich S, Schrøder HD, Rubinstein NA, Khurana TS. Transcriptional
and functional differences in stem cell populations isolated from extraocular
and limb muscles. Physiol Genomics 37: 35–42, 2009. First published
December 30, 2008; doi:10.1152/physiolgenomics.00051.2008.—The ex-
traocular muscles (EOMs) are a distinct muscle group that displays an
array of unique contractile, structural, and regenerative properties.
They also have differential sensitivity to certain diseases and are
enigmatically spared in Duchenne muscular dystrophy (DMD). The
EOMs are so distinct from other skeletal muscles that the term
“allotype” has been coined to highlight EOM group-specific proper-
ties. We hypothesized that increased and distinct stem cells may
underlie the continual myogenesis noted in EOM. The side population
(SP) stem cells were isolated and studied. EOMs had 15 higher SP
cell content compared with limb muscles. Expression profiling re-
vealed 348 transcripts that define the EOM-SP transcriptome. Over
92% of transcripts were SP specific, because they were absent in
previous whole muscle microarray studies. Cultured EOM-SP cells
revealed superior in vitro proliferative capacity. Finally, assays of the
committed progenitors or satellite cells performed on myofibers iso-
lated from EOM and limb muscles independently validated the in-
creased proliferative capacity of these muscles. We suggest a model in
which unique EOM stem cells contribute to the continual myogenesis
noted in EOM and consistent with a role for their sparing in DMD. We
believe the greater numbers of stem cells, their unique transcriptome, the
greater proliferative capacity of EOM stem cells, and the greater number
of satellite cells also offer clues for novel cell-based therapeutic strategies.
side population; microarrays; Duchenne muscular dystrophy
SKELETAL MUSCLES COMPRISE 40% of the total adult human
body mass and are responsible for a number of functions
including body support, force generation, and movement (20).
To accomplish a diverse range of functions, specialized groups
of muscles exist, exhibiting distinct properties (57). While the
exact mechanism(s) pertaining to the origin of this diversity
remains unclear, two main hypotheses have been proposed.
The first emphasizes the instructive role played by environ-
mental cues on a set of naive and noncommitted muscle
precursors (reviewed in Ref. 51), while the second focuses on
the role of lineage directives inherited by differentiating mus-
cle cells from specialized progenitors in phenotypically distinct
“allotypes” (25, 26) of muscles such as the extraocular muscles
(EOMs) and limb muscles.
Indeed, the EOM allotype epitomizes functional diversity,
because these specialized muscles are required to provide a
variety of voluntary, saccadic, and reflex eye movements. They
exhibit developmental, anatomic, metabolic, molecular, and
functional properties that are at great variance from other (e.g.,
limb) skeletal muscles (5). Embryologically, the EOMs de-
velop from prechordal mesoderm rather than somites (52) and
are innervated by cranial nerves rather than spinal cord mo-
toneurons. The EOM can be stimulated to twitch at extremely
high frequencies, in contrast to limb muscle, in which similar
frequencies of stimulation would lead to fusion and generation
of tetanic contractions (4). Adult EOM can be multiply inner-
vated and exhibit en grappe synapses, a pattern that is found in
fetal rather than adult mammalian limb muscle (49). The
expression pattern of myosin II isoforms in EOM is different
from that seen in limb muscles; adult EOMs express an
EOM-specific isoform (MYH13), continue to express the em-
bryonic isoform MYH3, and can coexpress multiple myosin
isoforms, in contrast to limb muscle (58, 59). EOM differs
from limb muscle at the level of the transcriptome (15, 16, 47,
53) and the proteome (17, 18) as well. Both transcriptome-
based analysis (15, 16) and cell labeling studies (40–42) have
suggested that adult, uninjured EOMs have ongoing myogen-
esis/regeneration, in contrast to limb muscle, in which signif-
icant expression of regeneration markers or myonuclear addi-
tion would only be noted in the context of regeneration after
injury or disease. But perhaps the diversity is most vividly
exemplified by the differential response to diseases such as the
congenital cranial dysinnervation disorders (12) and Duchenne
muscular dystrophy (DMD).
DMD is the most common fatal X-linked neuromuscular
disease. It is caused by mutations in the gene encoding dys-
trophin and affects 1 in 3,500 male newborns (24, 35). DMD is
a progressive disease that presents clinically during the first
decade of life, and patients become wheelchair dependent by
their teens. Classical signs and symptoms include weakness
and widespread muscle wasting, prominent calf enlargement,
spinal deformities, and respiratory problems. Patients usually
die in their thirties of respiratory and/or cardiac failure (11).
While widespread muscle necrosis is pathognomonic of DMD,
enigmatically, EOM function and histology are preserved in
DMD patients (29, 32).
Several hypotheses have been proposed to explain EOM
sparing in DMD; however, the exact mechanism(s) of sparing
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remain unclear (cf. DISCUSSION). On the basis of cell labeling
(40–42) and expression profiling (15, 16) studies, we and
others have proposed the hypothesis that the EOM may have a
greater myogenic/regeneration capacity; however, how the
greater myogenic capacity can be achieved has yet to be
addressed. Adult skeletal muscle has postpartum growth and
regenerative capacity due to the presence of muscle progeni-
tors, including committed progenitors or satellite cells (SCs)
that are capable of forming muscle (39, 75) as well as uncom-
mitted progenitors or stem cells that are capable of forming a
number of tissue types including muscle. A variety of cell
populations, such as side population (SP) cells (22), pericytes
(8), CD133 progenitor cells (1), and mesoangioblasts (61),
have all been suggested to form the muscle stem cell pool(s).
However, it remains an open question whether the stem cell
content, type, and myogenic capacity of EOMs are different
compared with limb muscles.
To address this question, we quantified and characterized
one stem cell population present in muscle, the SP cells, using
a variety of cellular and molecular methods. In this study, we
tested the hypothesis that an increased number of stem cells
present in EOM may explain the continuous regeneration and
subsequent sparing of these muscles in DMD.
MATERIALS AND METHODS
Animals. Twelve- to sixteen-week-old C57BL/10ScSnJ, C57BL/
10ScSn-Dmd mdx/J (Jackson Laboratory, Bar Harbor, ME), and
C57BL/6-Tg(ACTB-EGFP)1 Osb/J GFP (gift from Dr. Alan Flake,
Children’s Hospital of Philadelphia) mice were used for SP experi-
ments. Animal experiments were approved by the University of
Pennsylvania Institutional Animal Care and Use Committee and
conformed to the relevant regulatory standards.
SP cell preparations. SP cells were fractionated from EOM and
tibialis anterior (TA) muscles (n  5 mice) by flow cytometry as
previously described (44). Briefly, TA, quadriceps, and EOM were
dissected, weighed, minced, and placed in skeletal muscle medium
(SKM) [Ham’s F-10 with 20% FBS in 0.5% penicillin-streptomycin
(pen/strep)] at 4°C until digestion (all reagents from GIBCO-Invitro-
gen, Grand Island, NY, unless specified). Enzymatic digestion was
performed with 1.2 U/ml dispase and 5 mg/ml collagenase IV (Worth-
ington, Lakewood, NJ) for 45 min at 37°C and then quenched with
SKM. Cell suspensions were filtered through 70-m and 40-m cell
strainers, centrifuged (514 g) at 4°C, and resuspended in 3 ml of
medium.
Red blood corpuscle/ cells were lysed with NH4Cl, and the remain-
ing cells were resuspended at 106 cells/ml in PBS with 0.5% BSA
(Sigma). Verapamil (100 M, Sigma) was added to one aliquot of cells
and incubated 5 min at 37°C before 5 g/ml of Hoechst 33342
(Sigma) was added to all samples and incubated 60 min at 37°C.
Propidium iodide (PI, Sigma; 2 g/ml) was added to the samples
before fluorescence-activated cell sorting (FACS) with a BD LSRII
cell sorter (BD Biosciences, San Jose, CA). Flow cytometries were
analyzed with BD CellQuest Pro version 5.2 (BD Biosciences).
Details of SP cell preparation and gating strategy and yields are
provided in Supplemental Fig. S1 and Supplemental Table S1, respec-
tively.1 The amount of SP cells per gram of dry tissue was calculated
with the following equation: SP cell number per gram  number of
mononuclear cells per gram  (%viability/100)  (%SP cells/100).
Sca-1 and CD45 expression. Cells were incubated with 2 g/106
cells of primary or isotype control MAb (BD Biosciences Pharmin-
gen) for 15 min immediately after Hoechst staining, then cells were
washed and resuspended in 0.5 ml of cold PBS-BSA, and PI was
added before FACS analysis.
SP cell microarray hybridization and analysis. SP cell preparations
were washed, pelleted, and resuspended in 20 l of PBS and stored at
80°C until processing for microarray analysis according to manu-
facturer’s instructions and previously described methods from our
laboratory (6, 15). Total RNA was isolated with the RNeasy micro kit
(Qiagen, Valencia, CA). The purity, concentration, and integrity of
RNA were determined with a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE) and an Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA). RNAs were
subjected to linear amplification with the GeneChip two-cycle target-
labeling protocol (Affymetrix, Santa Clara, CA).
Six independently separated EOM and six TA SP cell preparations
were used for microarray analysis with Affymetrix Mouse 430 version
2.0 GeneChip arrays. One EOM and two TA SP cell GeneChip
hybridizations failed to meet quality control standards and were
discarded from further analysis. Raw intensities for each probe set
were stored in electronic formats with GeneChip Operating System
version 1.1, and expression summaries were calculated with Microar-
ray Suite version 5.0 (MAS5) algorithms. All data were normalized by
GC-RMA algorithm with Genespring version 7.3.1 software (Agilent)
and filtered separately to obtain at least one present call for each
transcript in any of nine conditions by using MAS5 output. Statistical
analysis was applied on 28,987 of 45,101 probe sets that passed the
filtering. Differentially expressed genes were identified by applying
the two-class unpaired data settings in Significant Microarray Anal-
ysis version 2.21 software at the level of 0% false discovery rate
(FDR). Verification of the accuracy of the analysis of relationships
between the samples was done by principal component analysis
(PCA) and visualization of the relative expression level of each
transcript with Pearson correlation-based hierarchical clustering of
samples using Genespring version 7.3.1 software (Agilent).
Validation of gene expression by quantitative PCR. Quantitative
PCR (qPCR) was performed as previously described (6, 15) in order
to validate differential expression of Dspg3, Fbln1, Mmp23, Cd36,
and Utrn on three independent EOM and TA SP cell preparations.
GAPDH expression was used for normalization. RNA from each
sample was reverse transcribed into cDNA with oligo(dT) primers and
amplified with an ABI 7900HT real-time PCR system (Applied
Biosystems, Foster City, CA) and gene-specific primers (Idaho Tech-
nology, Salt Lake City, UT). Sequence Detection Software (ABI,
Version 2.2) was used for analysis and the Ct method (where Ct is
threshold cycle) for computing gene expression levels as described
previously (37). Primer sequences and PCR conditions are provided in
Supplemental Table S2.
In vitro muscle formation assays. SP cells were cultured in vitro to
form myotubes with standard methods. Briefly, equal numbers of
EOM and TA SP cells [from green fluorescent protein (GFP) mice]
were resuspended in Rubinstein complete medium [69% DMEM,
17.3% M199, 9.7% horse serum, 0.97% chick embryo extract (SLI,
Bolney, UK), 1.04% glutamine, 1.04% pen/strep, 1.04% Fungizone]
and cultured alone or over a mdx myoblast feeding layer on glass-
bottomed 35-mm petri dishes or eight-well culture chamber slides
coated with Matrigel (BD Biosciences, Bedford, MA). The feeder
layer (2.7  104/cm2 myoblasts) was plated 1 h before SP cells were
plated. GFP cells and myotubes were counted with a Nikon Eclipse
TE 2000-U at 48–72 h and 13–18 days after plating. Myotube
formation was documented on 2-wk-old cultures stained with Hoechst
33342.
Statistical analysis. GraphPad Prism version 4.0, (GraphPad Soft-
ware, San Diego, CA) was used for statistical analysis, and a P value
0.05 was considered significant.
All primary microarray data are MIAME compliant, have been
deposited in NCBI’s Gene Expression Omnibus (GEO, http://www.
ncbi.nlm.nih.gov/geo/), and are accessible through GEO Series accession
number GSE9294.1 The online version of this article contains supplemental material.
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RESULTS
EOM contains a 15.7 greater number of SP cells per gram
than limb muscle. We evaluated the uncommitted stem cell
compartment by quantifying the numbers of SP cells based on
their ability to exclude Hoechst 33342 (21, 22, 44). This
strategy allows the purification of living SP cells from a muscle
mononuclear cell pool by FACS-based fractionation, without
having to expose the cells to culture conditions. As shown in
Fig. 1, we found that EOM (291,929 	 267,346) contains 15
times more SP cells per gram compared with TA (22,799 	
23,282; n  7; P  0.05). Over 95% of EOM-SP (96.62 	
4.02) and TA-SP (97.06 	 2.26) were CD45 (n  13).
Expression profiling of EOM vs. limb muscle SP cells. To
identify the expression profile of SP cells fractionated from
EOM versus limb muscle we performed microarray-based
screening using Affymetrix Mouse Genome 430 2.0 Array
GeneChips. We performed hierarchical clustering of nine sam-
ples to determine overall similarities within and between the
EOM-SP and TA-SP samples. Branch-length analysis of data
(Fig. 2A, top, red and cyan lines) demonstrated that the five
Fig. 1. Extraocular muscle (EOM) contains 15 times more side population
(SP) cells than tibialis anterior (TA). Total mononuclear cells from EOM and
TA were labeled with Hoechst 33342 in the presence and absence of verap-
amil. SP cell population was selected with a third log cutoff between main
population and SP in the density plots (see Supplemental Fig. S1). Values are
mean 	 SD numbers of SP cells per gram of tissue in EOM compared with
TA; n  7. *P  0.05.
Fig. 2. Microarray heat map, principal component analysis (PCA), and scatter
graph. A: hierarchical clustering analysis of all EOM-SP and TA-SP samples.
Unsupervised clustering in Genespring 7.2 version was used to analyze
similarities among replicate samples across sorted EOM-SP vs. TA-SP cells.
Similarities between samples are indicated by the length of the lines that are at
top of each sample column. Relative expression levels of 348 statistically
significant transcripts are shown as horizontal colored bars. Red color refers to
higher and blue color refers to lower expression as shown on scale bar.
Replicate sample names with purple and cyan color codes are indicated at
bottom. B: PCA: 3-dimensional plot showing distribution of EOM-SP (red) and
TA-SP (cyan) transcripts. The 3 axes correspond to the components with the
highest variance between the groups. C: microarray scatter graph of genes
differentially expressed between EOM-SP and TA-SP. Black, normalized
expression values of 313 transcripts (205 upregulated in EOM and 108 in TA)
on a logarithmic scale after a 2-fold cutoff between EOM-SP and TA-SP.
Gray, transcripts that did not pass the cutoff. The names of the highest-
expressed transcripts in EOM (Dspg3) and TA (CD36) are shown.
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EOM-SP samples were more similar to each other than to
TA-SP samples, and, vice versa, the four TA-SP samples were
more similar to each other than to EOM-SP. Further analysis of
the profiling with a FDR cutoff set at a highly stringent 0%
revealed 348 differentially expressed transcripts (0.77% of
45,101 evaluated transcripts) in the profile, of which 229 were
upregulated in EOM-SP and 119 upregulated in TA-SP. Figure
2A, bottom, shows the heat map representation of hierarchical
clustering of the entire profile. The complete list of 348
transcripts is provided in Supplemental Table S3.
To evaluate the overall relationship between the multivariate
profiles of SP cells isolated from EOM and TA, we performed
a PCA (62). Figure 2B shows the distribution of EOM-SP and
TA-SP chip data in three-dimensional space, where the three
axes correspond to the three components with highest variabil-
ity in our data set. As can be seen in Fig. 2B, EOM-SP chips
(red) and TA-SP chips (cyan) cluster as groups on different
coordinates, demonstrating that the biggest variance is due to
the tissue from which the SP cells were isolated.
To identify and graphically depict all the genes that were
differentially expressed at greater than twofold levels, we
performed a scatter graph analysis after imposing the fold
change cutoff. Even with this limitation, a majority of tran-
scripts (313 of 348 or 89.9%) were found to be differentially
expressed: 205 upregulated in EOM-SP and 108 upregulated in
TA-SP, as shown in Fig. 2C, which shows the two transcripts
(Dspg3 and Cd36) found to be differentially expressed with the
greatest magnitude of difference in the profile.
To validate the transcriptome analysis we performed qPCR
on five transcripts (3 upregulated in EOM-SP and 2 upregu-
lated in TA-SP) on RNA extracted from three independent
EOM-SP and TA-SP preparations. As shown in Table 1, qPCR
validated differential expression of Dspg3, Fbln1, Mmp23,
Cd36, and Utrn in SP cells fractionated from EOM and limb
muscle. Furthermore, as shown in Table 1, the magnitude of
change was consistent with levels of differential expression
revealed by microarray analysis.
Bioinformatic analysis of EOM and limb muscle SP cell
transcriptomes. We used different bioinformatic strategies to
further analyze the function of the genes that were found to be
differentially expressed in the EOM and limb muscle SP cell
transcriptomes. The bioinformatic program DAVID (version
2.1) was used to functionally cluster the entire list of differen-
tially expressed genes. Interestingly, DAVID-based analysis
led to clustering of 93 genes (from the 348 transcripts submit-
ted), and the largest number of genes were clustered in bio-
logical processes that are associated with muscle formation/
development, such as cell adhesion, morphogenesis, organ
development, cell differentiation, cell growth, and regulation
of growth and tissue development (Fig. 3A and Supplemental
Table S4). To address whether the differences in gene expres-
sion noted among the SP cell transcriptomes were due to the
previously reported differences between EOM and limb muscle
transcriptomes (15, 16, 47, 53) rather than SP cells, we com-
pared the previous “EOM vs. limb muscle” significant gene list
with the new list from the EOM-SP vs. limb-SP comparison;
we converted the original rat transcripts into their mouse
orthologs (total number 585), and then we intersected the 348
transcripts from the SP cell microarray. We observed that of
the 348 differentially expressed genes (i.e., upregulated in
EOM-SP and upregulated in TA-SP) in the SP microarray, 322
genes were SP specific and only 26 genes were present in the
previous (whole muscle) microarray comparison (Fig. 3B,
Supplemental Table S5), demonstrating that the vast majority
of genes identified in this study reflected differences in the
transcriptomes of EOM-SP and TA-SP cells rather than of the
tissue from which they were fractionated.
Fig. 3. Biological process (DAVID) and Venn diagram. A: biological pro-
cesses of genes differentially expressed between EOM-SP vs. TA-SP. With
DAVID 2.1, 93 of 322 genes that are available in DAVID database are grouped
based on Gene Ontology (GO; http://www.geneontology.org). Each biological
process is ranked based on its P value, indicating its overexpression. B: Venn
diagram representing stem cell-specific (EOM-SP vs. TA-SP cells) differen-
tially expressed transcripts against EOM vs. limb muscles (EOM vs. TA)
differentially expressed transcripts with 26-transcript overlap (92% concor-
dance, 8% discordance in expression levels).
Table 1. Validation of expression profiling
Affy ID Gene Symbol Microarray Fold qPCR Fold qPCR P Value
1421114_a_at Dspg3 338.4 259.3 3.99916E-07
1439688_at Fbln1 13.7 5.0 1.64621E-05
1417282_at Mmp23 7.6 2.3 1.95926E-06
1450884_at Cd36 69.9 26.0 3.09794E-06
1452222_at Utrn 2.7 9.0 1.50034E-07
Five of 348 differentially expressed transcripts revealed by the microarray
were independently validated by quantitative PCR (qPCR). Fold change of
expression in the microarray and in the qPCR are shown.
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Differences in myogenic potential of SP cells fractionated
from EOM and limb muscles. To ensure that the SP cells had
myogenic potential and were capable of forming myotubes
in vitro, we fractionated EOM-SP and TA-SP from GFP
mice. Equal numbers of these were plated on a myoblast
feeding layer made from mdx mice, and we evaluated them
after 13 days in culture. To determine the relative myogenic
potential in vitro, EOM-SP and TA-SP were cultured in par-
allel and the total number of GFP cells cultured per well was
evaluated at two time points: early (48–72 h) and late (2 wk).
We found that both EOM-SP and TA-SP were able to fuse and
form multinucleated myotubes in vitro as shown in Supple-
mental Fig. S3. (In one case, fusion of EOM-SP-derived GFP
cells to twitching myotubes was also observed, see Supple-
mental Movie S1; also see Supplemental Figs. S4–S6 for more
examples of cultured EOM-SP and TA-SP cells.) As shown in
Fig. 4B, at the early time point the number of GFP EOM-SP
cells was higher than TA-SP (110.5 	 16.3 vs. 35.0 	 15.6;
n  2, P  0.0001). Similarly, at the late time point (Fig. 4, A
and C) the number of GFP EOM-SP cells was higher than
TA-SP (528.3 	 453.7 vs. 47 	 25.36; n  3, P  0.05). As
independent validation of the increased proliferative capacity
of these muscles we have included Supplemental Fig. S2,
which shows SC counts performed on myofibers isolated from
EOM and limb muscles.
DISCUSSION
In adults, stem cells are known to reside in tissues undergo-
ing rapid turnover such as the hematopoietic system, gut lining,
and epidermis. Adult skeletal muscle is not associated with
rapid cell turnover compared with tissues such as the gut;
however, it has a limited ability to respond to physiological
stimuli such as increased workload and pathophysiological
insults such as trauma, disease, or toxins. SCs are critical for
the ability to regenerate and repair muscle; however, uncom-
mitted stem cell progenitors such as SP cells are also capable
of considerable myogenesis.
While previous studies have compared uncommitted SP
cells with main population cells (3, 46, 68) and SP cells from
different tissues and/or organs (22, 45, 56), no previous study
has compared the content of SP cells between different skeletal
muscle groups. In this study we found that the number of SP
cells per gram in EOM is 15 times the number in limb muscle.
Transcriptome analysis using Affymetrix GeneChips revealed
that 348 transcripts were found differentially expressed in
EOM-SP vs. TA-SP cells out of 45,101 evaluated transcripts
(which include 
34,000 well-characterized mouse genes).
Thus the vast majority (92%) of transcripts identified in this
study reflected transcriptome level differences between SP
cells obtained from different tissues rather than from the tissue
Fig. 4. EOM-SP cells proliferate better
in vitro than TA-SP cells. A: representative
culture of EOM and TA green fluorescent pro-
tein-positive (GFP) SP cells after 2 wk of
culture over a myoblast feeding layer. Equal
numbers of GFP SP cells were plated on a
mdx-myoblast feeding layer. After 18 days,
cells were counted. Left: EOM-SP. Right: TA-
SP. From top to bottom: GFP, Hoechst, phase,
and overlaid (Ov) images. B: a higher number
of EOM-SP cells than TA-SP cells was present
in culture 48–72 h after sorting. Cells were
counted with a fluorescence microscope.
Means 	 SD are shown; n  2. ***P 
0.0001. C: differences in the number of EOM
and TA GFP cells in cultures increased over
time. After 13–18 days, cells were counted
with a fluorescence microscope. Means 	 SD
are shown; n  3. *P  0.05.
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from which they were isolated (15, 16, 53). However, a small
fraction (8% or 26 of 348) of differentially expressed tran-
scripts could potentially be ascribed to differences in EOM and
limb muscle transcriptomes per se. This group included three
forms of Gst (Gst m4, Mgst 1, and Gst a4) and two isoforms of
UDP (33Galt1 and Galntl1) that were upregulated in EOM-SP
cells. The presence of high levels of chemoprotective enzymes
such as Gst and Udp offers an advantage in overcoming
oxidative stress; resistance to such stress has been described in
other stem cells (2, 63). Additionally, the bicoid class of
homeodomain transcription factor Pitx-2 was found to be
upregulated. Pitx-2 is an upstream activator of the myogenic
regulatory factors Myf5 and MyoD that plays an important role
in EOM and craniofacial muscle development. Indeed, muta-
tions of Pitx-2 lead to Axenfeld-Rieger syndrome associated
with craniofacial malformation and ocular and EOM dysgen-
esis (65).
Bioinformatic analysis of the transcriptomes revealed a
number of interesting differences between the EOM and limb
muscle stem cell transcriptomes. Genes found upregulated in
the EOM transcriptome included Tgfbi, Fn1, Aebp1, Dpt, Tro,
Alcam, and Col14a1 (23, 34, 69), which have been shown to be
expressed by stem cells in different tissues. Biological process
clustering with DAVID revealed differential expression of a
group of 26 cell adhesion molecules, including the endothelial
markers CD36 (10), Scarb1 (74), CD93 (76), Vwf (67), Myh9
(27), and Nrp2 (13), which were all downregulated in EOM-
SP. Interestingly, CD36 (14), Scarb1(74), and CD93(76) have
also been associated with fatty acid transmembrane transport
and clearance of apoptotic cells in different populations of stem
cells. The genes Nrp2, Kitl (9), Itga (73), and Dll1 (33) were
downregulated in EOM-SP cells and have been previously
associated with a proliferative stimulus for stem cells. Addi-
tionally, two tumor suppressor genes, Jup (71) and Stim2 (50,
60), were downregulated in the EOM-SP cells. Consistent with
the increasingly important role ascribed to the interaction
between stem cells and extracellular matrix in formation and
maintenance of stem cell niches (64), as well as the role played
by Tcf4, a downstream effector of Wnt--catenin signaling
pathway in chicken limb bud muscle pattern formation (30),
we found Dspg3, a small leucine-rich repeat protein greatly
upregulated in EOM-SP.
Analysis with KEGG (http://www.genome.ad.jp/kegg/
pathway.html) allowed identification of a number of candidate
pathways related to Notch, Vegf, Follistatin, and BMP signal-
ing as differentially regulated in the SP transcriptomes. Tran-
scriptional evidence of Notch pathway inhibition in EOM-SP
comes from the downregulation of DLL1, Notch 1, Nrarp, and
Evi1 and upregulation of the inhibitor HDAC4. Previous stud-
ies (48, 66) have demonstrated that Notch inhibits muscle
differentiation and blockade of Notch signaling either by g-
secretase inhibition or by Numb overexpression causes myo-
tube hypertrophy by recruiting reserve cells that do not nor-
mally fuse (33). Vegf, VEGFR1, and Cdc42 were found to be
downregulated in EOM for reasons that are unclear since the
EOM are highly vascular; however, this may reflect heteroge-
neity of different stem cell populations in muscle. FST, Fstl-1,
Tmeff2, and HDAC4 (7, 19, 28, 36, 43) were upregulated,
suggesting mechanisms by which EOM could have more
efficient myogenesis. Bmp1, Bmpr1b, Htra1, Twsg1, and Rgmb
genes were upregulated in EOM-SP cells and are interesting in
the context of FST and myogenesis since the metalloprotease
Bmp1 is known to cleave the myostatin propeptide and activate
latent myostatin (72). Consistent with the transcriptome-level
differences identified here, it has been reported that SP cells
fractionated from skin and muscle differ in their capacity to
restore dystrophin, suggesting that inherent differences exist
even among the same stem cell populations isolated from
different tissues (45). The limited numbers of surviving cells in
these reports provide an important impetus toward efforts to
identify and study myogenic progenitors from different tissue
sources to increase the likelihood of making these approaches
therapeutically effective in DMD. The differential expression
of these genes may reflect mechanisms enabling EOM-SP cells
to undertake the more efficient myogenesis previously noted in
EOM (15, 16, 40–42). We found that EOM-SPs were able to
proliferate more efficiently compared with TA-SPs, after equal
numbers of them were cultured up to 2 wk in vitro, despite
identical matrix/culture conditions. Together, these findings
support a role of lineage directives inherited by differentiating
muscle cells from specialized progenitors in phenotypically
distinct “allotypes” such as the EOM.
From a disease perspective, several hypotheses have been
proposed to explain the enigmatic EOM sparing in DMD,
including smaller surface-to-volume ratio resulting in less
mechanical stress (31), higher capacity to regulate intracellular
calcium in EOM than other skeletal muscles (32), higher
antioxidant capacity in EOM (55), overexpression of dystro-
phin-related protein (DRP)/utrophin (38, 54), increased elas-
ticity due to differential expression of M bands (70), and
Fig. 5. Model for the role of stem cells in EOM sparing in Duchenne muscular
dystrophy (DMD). Flow chart summarizes findings from stem cell quantita-
tion, microarray, and in vitro studies. Left: EOM. Right: TA. We believe that
an increased and unique stem cell content underlies the continuous myogenesis
observed in normal EOM muscle and may explain the EOM sparing in DMD.
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increased myogenesis (15, 16, 40–42). However, independent
tests of these hypotheses either have not been performed or
have been equivocal, e.g., DRP/utrophin upregulation where
utrophin upregulation has not been confirmed at the protein or
mRNA level (15, 16, 32, 53). Our identification in EOM of a
unique stem cell content with greater numbers of SP cells with
a specific expression profile coupled with the greater capacity
of these cells for in vitro myogenesis provides a model (Fig. 5)
and support for the hypothesis that an increased stem cell
content may underlie the efficient and continual myogenesis
and therefore may contribute to sparing of adult EOM in DMD.
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